We have taken many steps this summer to getting Shylicine approved for use in treating microvillus inclusion disease, a rare pediatric disorder that causes chronic diarrhea. Our goal with this oral anti-diarrheal treatment is to restore intestinal function so patients can eat and drink normally...
Shylicine™ is a cocktail that is developed with the ultimate goal of eliminating the need for TPN in Microvillus Inclusion Disease (MVID) patients.